These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 31348083
41. Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection. Huang J, Huang L, Zhou J, Duan Y, Zhang Z, Wang X, Huang P, Tan S, Hu P, Wang J, Huang M. Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134 [Abstract] [Full Text] [Related]
42. The diagnosis and management of extramammary Paget's disease. Ito T, Kaku-Ito Y, Furue M. Expert Rev Anticancer Ther; 2018 Jun; 18(6):543-553. PubMed ID: 29575944 [Abstract] [Full Text] [Related]
43. Docetaxel Combined With Cisplatin for Metastatic Extramammary Paget Disease. Cai H, Xu W, Yu B, Li X, Zhu L, Xu Z, Zhou J, Zheng Y, Zou Q, Zeng Y, Wang X, Xu T. Clin Genitourin Cancer; 2018 Aug; 16(4):e899-e901. PubMed ID: 29685612 [Abstract] [Full Text] [Related]
49. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease. Cho Z, Konishi E, Kanemaru M, Isohisa T, Arita T, Kawai M, Tsutsumi M, Mizutani H, Takenaka H, Ozawa T, Tsuruta D, Katoh N, Asai J. J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343 [Abstract] [Full Text] [Related]
50. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study. Caobelli F, Alongi P, Evangelista L, Picchio M, Saladini G, Rensi M, Geatti O, Castello A, Laghai I, Popescu CE, Dolci C, Crivellaro C, Seghezzi S, Kirienko M, De Biasi V, Cocciolillo F, Quartuccio N, Young AIMN Working Group. Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775 [Abstract] [Full Text] [Related]
51. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy. Yamazaki N, Yamamoto A, Wada T, Ishikawa M, Moriya Y, Nakanishi Y. J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432 [Abstract] [Full Text] [Related]
52. Prognostic indicators in 35 patients with extramammary Paget's disease. Ito Y, Igawa S, Ohishi Y, Uehara J, Yamamoto AI, Iizuka H. Dermatol Surg; 2012 Dec; 38(12):1938-44. PubMed ID: 22989161 [Abstract] [Full Text] [Related]
53. Extramammary Paget's disease with aggressive behavior: a report of two cases. Kim JC, Kim HC, Jeong CS, Cho MK, Koh KS, Gong G, Koh JK, Lee MG. J Korean Med Sci; 1999 Apr; 14(2):223-6. PubMed ID: 10331574 [Abstract] [Full Text] [Related]
54. Lack of clinical impact of 18 F-fluorodeoxyglucose positron emission tomography with simultaneous computed tomography for stage I and II Merkel cell carcinoma with concurrent sentinel lymph node biopsy staging: A single institutional experience from Westmead Hospital, Sydney. Liu J, Larcos G, Howle J, Veness M. Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330 [Abstract] [Full Text] [Related]
55. Fluorine-18-FDG PET in Paget's disease of bone. Cook GJ, Maisey MN, Fogelman I. J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817 [Abstract] [Full Text] [Related]
56. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. Pierie JP, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ. J Am Coll Surg; 2003 Jan; 196(1):45-50. PubMed ID: 12517548 [Abstract] [Full Text] [Related]
58. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Lee M, Jeon JY, Neugent ML, Kim JW, Yun M. Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188 [Abstract] [Full Text] [Related]
59. Radiation therapy for lymph node metastasis from extramammary Paget's disease. Hata M, Koike I, Wada H, Minagawa Y, Kasuya T, Matsui T, Suzuki R, Takano S, Inoue T. J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):873-7. PubMed ID: 23663098 [Abstract] [Full Text] [Related]
60. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival. Kim HR, Seo M, Nah YW, Park HW, Park SH. Nucl Med Commun; 2018 Jul; 39(7):691-698. PubMed ID: 29893751 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]